Fotemustine and dacarbazine plus recombinant interferon alpha 2a in thetreatment of advanced melanoma.
Comella P, Daponte A, Casaretti R, Ionna F, Fiore F, Presutti F, Frasci G, Caponigro F, Gravina A, Parziale AP, Mozzillo N, Comella G.
Comella P, et al. Among authors: comella g.
Eur J Cancer. 1997 Jul;33(8):1326-9. doi: 10.1016/s0959-8049(97)00120-2.
Eur J Cancer. 1997.
PMID: 9301463
Clinical Trial.